Trademark: 98179729
Word
ZILBRYSQ
Status
Pending
Status Code
680
Status Date
Monday, May 13, 2024
Serial Number
98179729
Mark Type
4
Filing Date
Thursday, September 14, 2023

Trademark Owner History

Classifications
5 Pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory disorder, a wound, a burn, an autoimmune disorder, a pulmonary disorder, a cardiovascular disorder, a neurological disorder, a kidney-related disorder, a diabetes-related disorder, an ocular disorder, and a pregnancy-related disorder; Pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical preparations for the treatment of fibrotic and inflammatory disorders; Pharmaceutical preparations for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations as anti-viral, anti-bacterial, or anti-fungal agents
10 Syringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication

Trademark Events
Sep 18, 2023
New Application Entered
Oct 3, 2023
New Application Office Supplied Data Entered
Dec 8, 2023
Teas Voluntary Amendment Received
Apr 30, 2024
Assigned To Lie
May 10, 2024
Teas/Email Correspondence Entered
May 10, 2024
Correspondence Received In Law Office
Apr 30, 2024
Correspondence Received In Law Office
Apr 30, 2024
Teas/Email Correspondence Entered
May 8, 2024
Non-Final Action E-Mailed
May 8, 2024
Assigned To Examiner
May 8, 2024
Non-Final Action Written
May 8, 2024
Notification Of Non-Final Action E-Mailed
May 10, 2024
Teas Response To Office Action Received
May 13, 2024
Approved For Pub - Principal Register

Trademark Alertz updated from USPTO on 2030-01-24